Novavax, Inc. (NVAX) Dividend History

Novavax, Inc. is an American vaccine development company headquartered in Gaithersburg, Maryland, with additional facilities in Rockville, Maryland and Uppsala, Sweden. As of 2020, it has an ongoing Phase III clinical trial in older adults for its candidate vaccine for seasonal influenza, NanoFlu and a candidate vaccine for prevention of COVID-19. In June 2013, Novavax acquired the Matrix-M adjuvant platform with the purchase of Swedish company Isconova AB and renamed its new subsidiary Novavax AB.

Last update 07/30/2021


Dividend Yield Summary

  2016 2017 2018 2019 2020 2021
Dividends - - - - - -
Average Price 4.76 1.17 1.76 3.74 69.30 191.92
Yield - - - - - -
• The above Dividend, Average Price, and Yield values for 2021 are year-to-date.

Dividend History

No history of dividends
Date Amount Per Share Note